Written Answers. - Cancer Incidence.

Trevor Sargent

Ceist:

256 Mr. Sargent asked the Minister for Health and Children the number of cancer cases recorded in the Mid-Western Health Board area and the North-Western Health Board area for each of the past five years. [19233/03]

Cancer statistics are collated by the National Cancer Registry. Registry data is complete for 1994 to 1999 inclusive. The information requested by the Deputy in respect of the number of cancer cases recorded in the Mid-Western Health Board area and the North-Western Health Board area is provided by the National Cancer Registry for the years 1994 to 2001 inclusive. However, the data in relation to 2000 and 2001 is preliminary only and final results presented at a later date may differ from those listed in the following tabular statements:

Table 1: All Invasive Cancers

Year ofIncidence

Mid-WesternHealth Board

North-WesternHealth Board

1994

1,380

1,121

1995

1,276

1,087

1996

1,236

1,105

1997

1,327

1,100

1998

1,414

1,076

1999

1,276

1,060

2000*

1,470

1,145

2001*

1,401

1,249

*Preliminary data only – final results at a later date may differ.
Table 2: All Invasive Cancers excluding Non-Melanoma Skin Cancer

Year ofIncidence

Mid-WesternHealth Board

North-WesternHealth Board

1994

994

804

1995

914

751

1996

904

816

1997

992

784

1998

1,029

799

1999

928

766

2000*

1,093

886

2001*

1,035

951

*Preliminary data only – final results at a later date may differ.
Since the implementation of the national cancer strategy commenced in 1997, there has been a cumulative additional investment of approximately €400 million in the development of appropriate treatment and care services for people with cancer. This includes the sum of €29 million which was provided this year to ensure that we continue to address increasing demands in cancer services in such areas as oncology-haematology services, oncology drug treatments and symptomatic breast disease services. Cancer services throughout the country have benefited from this investment which far exceeds the £25 million requirement which was initially envisaged under the national cancer strategy. This investment has enabled the funding of 85 additional consultant posts, together with support staff in key areas such as medical oncology, radiology, palliative care, histopathology and haematology.